Transformative Biotech is advancing its patented extraction-free PCR buffer and sample media platform, which eliminates the nucleic acid extraction step from molecular testing. Validation on over 590,000 clinical samples in a former CLIA lab demonstrated faster, more cost-effective results without compromising accuracy.

We are raising a seed round to complete 510(k) studies, expand independent infectious disease validation studies, and establish OEM partnerships to scale decentralized PCR testing.

We are also developing our @ANYWHERE™ handheld PCR concept for future self-administered, smartphone-connected testing.